+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Conjugate Vaccine Market by Product Type, Age Group, Distribution Channel, Technology, End User - Global Forecast to 2030- Product Image
Conjugate Vaccine Market by Product Type, Age Group, Distribution Channel, Technology, End User - Global Forecast to 2030- Product Image
Sale

Conjugate Vaccine Market by Product Type, Age Group, Distribution Channel, Technology, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896495
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The conjugate vaccine market spectrum is advancing dynamically, having expanded from USD 43.92 billion in 2024 to an anticipated USD 81.51 billion by 2030, reflecting a compound annual growth rate (CAGR) of 10.85%.

Innovations Shaping Conjugate Vaccines

Conjugate vaccines are revolutionizing immunization efforts by linking polysaccharide antigens to protein carriers, such as CRM197, which amplify immune responses against pathogens like Haemophilus influenzae type b, pneumococcus, and meningococcus. These vaccines are integral to global public health strategies, significantly reducing disease and death rates. The report offers a comprehensive analysis of technological advancements, regulatory environments, and distribution model evolutions, all of which are essential for public health decision-makers navigating a competitive landscape.

Breakthroughs in Vaccine Development

Technological advancements in carrier proteins and adjuvant systems are setting new benchmarks for efficacy and production efficiency. Novel platforms and carrier enhancements have improved vaccine robustness, while regulatory bodies have streamlined priority candidate approvals without compromising safety. Strategic collaboration among pharmaceutical companies, contract manufacturing organizations, and global health bodies is innovating vaccine delivery systems to address diverse population needs effectively.

Impact of 2025 U.S. Tariffs

The imposition of U.S. tariffs in 2025 on vaccine carriers and related components has altered supply chain dynamics and pricing strategies. Manufacturers have adapted by exploring dual-sourcing solutions and relocating production to mitigate cost impacts, leading to increased complexity in quality and regulatory adherence. Agile risk management and proactive industry engagement are crucial for balancing tariff effects while sustaining market competitiveness.

Key Takeaways from This Report

  • Technological innovations in conjugate vaccines, including CRM197 carriers, are enhancing immunogenic coverage.
  • Strategic partnerships and digital supply chain management are vital for efficient vaccine distribution and scaling.
  • Tariff-related challenges require adaptive sourcing strategies and industry-stakeholder collaboration.
  • Age-specific and regional insights support targeted market strategies, optimizing procurement and public health outcomes.

Market Segment Analysis

This report categorizes the conjugate vaccine market across various dimensions, providing strategic insights tailored to specific segments:

  • Product Type: Hib, Pneumococcal, and Meningococcal Conjugate Vaccines
  • Age Group: From infants to elderly, highlighting growth opportunities in each demographic
  • Distribution Channel: Evaluates the role of clinics, hospitals, online platforms, and pharmacies in vaccine delivery
  • Technology: Focus on CRM197 and alternative formulations
  • End-User Sectors: Private and public healthcare facilities

Regional Dynamics

Regional analysis reveals diverse market drivers. The Americas benefit from robust public health systems, whereas Europe, the Middle East & Africa leverage regulatory harmonization for market entry. In Asia-Pacific, demand is buoyed by rising middle-income populations and expanding healthcare infrastructures, offering a strategic advantage for domestic and regional manufacturers.

Leading Industry Participants

Key players such as Pfizer, GlaxoSmithKline, and Sanofi have invested in carrier molecules and adjuvant systems. Meanwhile, emerging biotech firms focus on niche formulations to address specific challenges. Collaborative efforts with academic institutions and logistics providers further enhance vaccine delivery frameworks.

Conclusion

As the conjugate vaccine market evolves, strategic imperatives include investment in scalable manufacturing technologies, nearshoring, and adaptation of product offerings to demographic nuances. Strong partnerships with public health authorities and a focus on digital channels will be critical in facilitating access and maintaining market momentum. The rigorous methodological framework of this report ensures decision-makers are equipped with actionable insights for informed strategic planning.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Conjugate Vaccine Market, by Product Type
8.1. Introduction
8.2. Hib Conjugate Vaccine
8.3. Meningococcal Conjugate Vaccine
8.4. Pneumococcal Conjugate Vaccine
9. Conjugate Vaccine Market, by Age Group
9.1. Introduction
9.2. Adolescents
9.3. Adults
9.3.1. 19 to 40 Years
9.3.2. 41 to 60 Years
9.4. Children
9.4.1. 2 to 5 Years
9.4.2. 6 to 12 Years
9.5. Elderly
9.6. Infants
9.6.1. 0 to 12 Months
9.6.2. 13 to 24 Months
10. Conjugate Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Clinics
10.3. Hospitals
10.4. Online
10.5. Pharmacies
11. Conjugate Vaccine Market, by Technology
11.1. Introduction
11.2. Crm197
11.3. Dt
11.4. Tt
12. Conjugate Vaccine Market, by End User
12.1. Introduction
12.2. Private Clinics
12.3. Private Hospitals
12.4. Public Clinics
12.5. Public Hospitals
13. Americas Conjugate Vaccine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Conjugate Vaccine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Conjugate Vaccine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. GlaxoSmithKline plc
16.3.3. Sanofi S.A.
16.3.4. Merck & Co., Inc.
16.3.5. Serum Institute of India Pvt. Ltd.
16.3.6. Bharat Biotech International Ltd.
16.3.7. Panacea Biotec Ltd.
16.3.8. SK bioscience Co., Ltd.
16.3.9. Bavarian Nordic a/S
16.3.10. Biological E. Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CONJUGATE VACCINE MARKET MULTI-CURRENCY
FIGURE 2. CONJUGATE VACCINE MARKET MULTI-LANGUAGE
FIGURE 3. CONJUGATE VACCINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CONJUGATE VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CONJUGATE VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONJUGATE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONJUGATE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY HIB CONJUGATE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY MENINGOCOCCAL CONJUGATE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PNEUMOCOCCAL CONJUGATE VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY 19 TO 40 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY 41 TO 60 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY 2 TO 5 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY 6 TO 12 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY 0 TO 12 MONTHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY 13 TO 24 MONTHS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY CRM197, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY DT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY TT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PUBLIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONJUGATE VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONJUGATE VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 59. CANADA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 60. CANADA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 61. CANADA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 62. CANADA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. CANADA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. CANADA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. GERMANY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 111. GERMANY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. GERMANY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. GERMANY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. FRANCE CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 132. ITALY CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 133. ITALY CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 134. ITALY CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 135. ITALY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. ITALY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ITALY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. SPAIN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 143. SPAIN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SPAIN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SPAIN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. QATAR CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 189. QATAR CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 190. QATAR CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 191. QATAR CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. QATAR CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. QATAR CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. FINLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. EGYPT CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. EGYPT CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. POLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. POLAND CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. POLAND CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 253. POLAND CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 254. POLAND CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 255. POLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. POLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. POLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC CONJUGATE VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. CHINA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 277. CHINA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 278. CHINA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 279. CHINA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 280. CHINA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. CHINA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. CHINA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. INDIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. INDIA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 285. INDIA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 286. INDIA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 287. INDIA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 288. INDIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. INDIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. INDIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 326. THAILAND CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 327. THAILAND CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 328. THAILAND CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 329. THAILAND CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. THAILAND CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 346. MALAYSIA CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 348. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 349. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 350. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 351. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 353. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 354. SINGAPORE CONJUGATE VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 355. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 356. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 357. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 358. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 359. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY INFANTS, 2018-2030 (USD MILLION)
TABLE 360. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 361. VIETNAM CONJUGATE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD

Companies Mentioned

The companies profiled in this Conjugate Vaccine market report include:
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech International Ltd.
  • Panacea Biotec Ltd.
  • SK bioscience Co., Ltd.
  • Bavarian Nordic A/S
  • Biological E. Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 81.51 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Conjugate Vaccine Market Size, Share & Trends Analysis Report By Product (Monovalent, Multivalent), By Brand (Prevnar, CAPVAXIVE), By Disease, By Pathogen, By Patient, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Conjugate Vaccine Market Size, Share & Trends Analysis Report By Product (Monovalent, Multivalent), By Brand (Prevnar, CAPVAXIVE), By Disease, By Pathogen, By Patient, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Conjugate Vaccines - Global Strategic Business Report - Product Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Conjugate Vaccine Market Report 2025 - Product Image

Conjugate Vaccine Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Conjugate Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Conjugate Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Conjugate Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Conjugate Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 86 Pages
  • Global
From

About the Conjugate Vaccine Market

The Conjugate Vaccine market is a subset of the Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Conjugate Vaccines are a type of vaccine that combines a polysaccharide antigen with a protein carrier, which helps the body to recognize the antigen and mount an immune response. These vaccines are used to protect against a variety of bacterial infections, including meningitis, pneumonia, and sepsis. Conjugate Vaccines are typically administered to infants and young children, as their immune systems are not yet fully developed and are more susceptible to certain infections. In addition, these vaccines are often used in combination with other vaccines to provide broader protection against multiple diseases. Notable companies in the Conjugate Vaccine market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.